Chlamydophila pneumoniae infection and its role in neurological disorders

Interdisciplinary Perspectives on Infectious Diseases

Volumn 2010, Issue , 2010, Pages

  Contini, Carlo ^a   Seraceni, Silva ^a   Cultrera, Rosario ^a   Castellazzi, Massimiliano ^a   Granieri, Enrico ^a   Fainardi, Enrico ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ATHEROGENESIS; ATHEROMA; BACTERIUM CULTURE; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW;

EID: 77953427362     PISSN: 1687708X     EISSN: 16877098     Source Type: Journal    
DOI: 10.1155/2010/273573     Document Type: Review

References (175)

1. Everett K. D. E., Bush R. M., Andersen A. A., Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms International Journal of Systematic Bacteriology 1999 49 2 415 440 (Pubitemid 129755047)
2. Saikku P., Leinonen M., Mattila K. et al., Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction The Lancet 1988 2 8618 983 986
3. Kleemola M., Saikku P., Visakorpi R., Wang S. P., Grayston J. T., Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland Journal of Infectious Diseases 1988 157 2 230 236 (Pubitemid 18061234)
4. Kuo C.-C., Jackson L. A., Campbell L. A., Grayston J. T., Chlamydia pneumoniae (TWAR) Clinical Microbiology Reviews 1995 8 4 451 461
5. Mordhorst C. H., Wang S. P., Grayston J. T., Outbreak of Chlamydia pneumoniae infection in four farm families European Journal of Clinical Microbiology and Infectious Diseases 1992 11 7 617 620
6. Yucesan C., Sriram S., Chlamydia pneumoniae infection of the central nervous system Current Opinion in Neurology 2001 14 3 355 359 (Pubitemid 32510601)
7. Stratton C. W., Sriram S., Association of Chlamydia pneumoniae with central nervous system disease Microbes and Infection 2003 5 13 1249 1253 (Pubitemid 37410258)
8. Stratton C. W., Mitchell W. M., The immunopathology of chlamydial infections Antimicrobics and Infectious Diseases Newsletter 1997 16 12 89 94
9. Ciervo A., Visca P., Petrucca A., Biasucci L. M., Maseri A., Cassone A., Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease Clinical and Diagnostic Laboratory Immunology 2002 9 1 66 74 (Pubitemid 34084277)
10. Mahdi O. S., Horne B. D., Mullen K., Muhlestein J. B., Byrne G. I., Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease Circulation 2002 106 13 1659 1663
11. Leinonen M., Saikku P., Evidence for infectious agents in cardiovascular disease and atherosclerosis Lancet Infectious Diseases 2002 2 1 11 17 (Pubitemid 36109301)
12. Campbell L. A., Kuo C.-C., Chlamydia pneumoniae: an infectious risk factor for atherosclerosis? Nature Reviews Microbiology 2004 2 1 23 32 (Pubitemid 39490045)
13. Mussa F. F., Chai H., Wang X., Yao Q., Lumsden A. B., Chen C., Chlamydia pneumoniae and vascular disease: an update Journal of Vascular Surgery 2006 43 6 1301 1307 (Pubitemid 43825695)
14. Palikhe A., Lokki M.-L., Saikku P. et al., Association of Chlamydia pneumoniae infection with HLA-B35 in patients with coronary artery disease Clinical and Vaccine Immunology 2008 15 1 55 59 (Pubitemid 351966527)
15. Byrne G. I., Chlamydia uncloaked Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8040 8042
16. Byrne G. I., Ojcius D. M., Chlamydia and apoptosis: life and death decisions of an intracellular pathogen Nature Reviews Microbiology 2004 2 10 802 808
17. Boman J., Söderberg S., Forsberg J. et al., High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors Journal of Infectious Diseases 1998 178 1 274 277 (Pubitemid 28328107)
18. MacIntyre A., Abramov R., Hammond C. J., Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells Journal of Neuroscience Research 2003 71 5 740 750 (Pubitemid 36255358)
19. Kuo C. C., Campbell L. A., Chlamydial infections of the cardiovascular system Frontiers in Bioscience 2003 8 e36 e43
20. Peeling R. W., Wang S.-P., Grayston J. T. et al., Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results Journal of Infectious Diseases 2000 181 6, supplement 3 S426 S429
21. Apfalter P., Chlamydia pneumoniae, stroke, and serological associations: anything learned from the atherosclerosis-cardiovascular literature or do we have to start over again? Stroke 2006 37 3 756 758 (Pubitemid 43731893)
22. Mackman N., Lipopolysaccharide induction of gene expression in human monocytic cells Immunologic Research 2000 21 2-3 247 251
23. Kalayoglu M. V., Indrawati L., Morrison R. P., Morrison S. G., Yuan Y., Byrne G. I., Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage- lipoprotein interactions Journal of Infectious Diseases 2000 181 6, supplement 3 S483 S489 (Pubitemid 30416125)
24. Fong I. W., Chiu B., Viira E., Tucker W., Wood H., Peeling R. W., Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques Journal of Infectious Diseases 2002 186 10 1469 1473 (Pubitemid 35286115)
25. Huittinen T., Leinonen M., Tenkanen L. et al., Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 3 431 437 (Pubitemid 34218750)
26. Wimmer M. L. J., Sandmann-Strupp R., Saikku P., Haberl R. L., Association of chlamydial infection with cerebrovascular disease Stroke 1996 27 12 2207 2210 (Pubitemid 26427194)
27. Elkind M. S. V., Lin I.-F., Grayston J. T., Sacco R. L., Chlamydia pneumoniae and the risk of first ischemic stroke: the Northern Manhattan Stroke Study Stroke 2000 31 7 1521 1525
28. Piechowski-Jwiak B., Mickielewicz A., Gaciong Z., Berent H., Kwieciski H., Elevated levels of anti- Chlamydia pneumoniae IgA and IgG antibodies in young adults with ischemic stroke Acta Neurologica Scandinavica 2007 116 3 144 149 (Pubitemid 47262760)
29. Madre J. G., Garcia J. L. R., Gonzalez R. C. et al., Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke European Journal of Neurology 2002 9 3 303 306
30. Elkind M. S. V., Tondella M. L. C., Feikin D. R., Fields B. S., Homma S., Di Tullio M. R., Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke Stroke 2006 37 3 790 795 (Pubitemid 43731910)
31. Heuschmann P. U., Neureiter D., Gesslein M. et al., Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: results from a population-based case-control study Stroke 2001 32 10 2253 2258 (Pubitemid 32954790)
32. Anzini A., Cassone A., Rasura M. et al., Chlamydia pneumoniae infection in young stroke patients: a case-control study European Journal of Neurology 2004 11 5 321 327 (Pubitemid 38903565)
33. Vink A., Poppen M., Schoneveld A. H., Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual Circulation 2001 103 12 1613 1617
34. Numazaki K., Chibar S., Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS Neurology 2001 57 4 746
35. Dowell S. F., Peeling R. W., Boman J. et al., Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada) Clinical Infectious Diseases 2001 33 4 492 502
36. Boman J., Hammerschlag M. R., Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies Clinical Microbiology Reviews 2002 15 1 1 20
37. Ieven M. M., Hoymans V. Y., Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence Journal of Clinical Microbiology 2005 43 1 19 24
38. Littman A. J., Jackson L. A., White E., Thornquist M. D., Gaydos C. A., Vaughan T. L., Interlaboratory reliability of microimmunofluorescence test for measurement of Chlamydia pneumoniae -specific immunoglobulin A and G antibody titers Clinical and Diagnostic Laboratory Immunology 2004 11 3 615 617
39. Maggi P., Monno R., Chirianni A., Role of Chlamydia infection in the pathogenesis of atherosclerotic plaques in HIV-1-positive patients In Vivo 2006 20 3 409 414
40. Tositti G., Rassu M., Fabris P., Chlamydia pneumoniae infection in HIV-positive patients: prevalence and relationship with lipid profile HIV Medicine 2005 6 1 27 32
41. Gaona-Flores V., Garca-Elorriaga G., Valerio-Minero M., Anti-Chlamydophila pneumoniae antibodies as associated factor for carotoid atherosclerosis in patients wit AIDS Current HIV Research 2008 6 3 267 271
42. Apfalter P., Assadian O., Blasi F., Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols Journal of Clinical Microbiology 2002 40 12 4428 4434
43. Sessa R., Di Pietro M., Schiavoni G., Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease Journal of Vascular Surgery 2003 37 5 1027 1031
44. Palikhe A., Tiirola T., Puolakkainen M., Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum Scandinavian Journal of Infectious Diseases 2009 41 3 201 205
45. Gieffers J., Füllgraf H., Jahn J. et al., Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment Circulation 2001 103 3 351 356
46. Gieffers J., Rupp J., Gebert A., Solbach W., Klinger M., First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniae Antimicrobial Agents and Chemotherapy 2004 48 4 1402 1405
47. Grayston J. T., Kronmal R. A., Jackson L. A. et al., Azithromycin for the secondary prevention of coronary events The New England Journal of Medicine 2005 352 16 1637 1645
48. Balin B. J., Grard H. C., Arking E. J. et al., Identification and localization of Chlamydia pneumoniae in the Alzheimers brain Medical Microbiology and Immunology 1998 187 1 23 42
49. Nochlin D., Shaw C. M., Campbell L. A., Kuo C.-C., Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimers disease Neurology 1999 53 8 1888 (Pubitemid 29530379)
50. Gieffers J., Reusche E., Solbach W., Maass M., Failure to detect Chlamydia pneumoniae in brain sections of Alzheimers disease patients Journal of Clinical Microbiology 2000 38 2 881 882 (Pubitemid 30082702)
51. Ring R. H., Lyons J. M., Failure to detect Chlamydia pneumoniae in the late-onset Alzheimers brain Journal of Clinical Microbiology 2000 38 7 2591 2594 (Pubitemid 30485135)
52. Taylor G. S., Vipond I. B., Paul I. D., Matthews S., Wilcock G. K., Caul E. O., Failure to correlate C. pneumoniae with late onset Alzheimers disease Neurology 2002 59 1 142 143 (Pubitemid 34742814)
53. Wozniak M. A., Cookson A., Wilcock G. K., Itzhaki R. F., Absence of Chlamydia pneumoniae in brain of vascular dementia patients Neurobiology of Aging 2003 24 6 761 765 (Pubitemid 37288852)
54. Gérard H. C., Dreses-Werringloer U., Wildt K. S., Chlamydophila (Chlamydia) pneumoniae in the Alzheimers brain FEMS Immunology and Medical Microbiology 2006 48 3 355 366 (Pubitemid 44736574)
55. Balin B. J., Appelt D. M., Role of infection in Alzheimers disease Journal of the American Osteopathic Association 2001 101 12, supplement 1 S1 S6
56. Keefover R. W., The clinical epidemiology of Alzheimers disease Neurologic Clinics 1996 14 2 337 351
57. Kawas C., Gray S., Brookmeyer R., Fozard J., Zonderman A. et al., Age-specific incidence rates of Alzheimers disease: the Baltimore Longitudinal Study of Aging Neurology 2000 54 11 2072 2077 (Pubitemid 30397204)
58. Di Carlo A., Baldereschi M., Amaducci L. et al., Incidence of dementia, Alzheimers disease, and vascular dementia in Italy. The ILSA study Journal of the American Geriatrics Society 2002 50 1 41 48 (Pubitemid 34053021)
59. Ravaglia G., Forti P., Maioli F. et al., Incidence and etiology of dementia in a large elderly Italian population Neurology 2005 64 9 1525 1530 (Pubitemid 40617687)
60. Evans D. A., Bennett D. A., Wilson R. S. et al., Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status Archives of Neurology 2003 60 2 185 189
61. Brookmeyer R., Gray S., Kawas C., Projections of Alzheimers disease in the United States and the public health impact of delaying disease onset American Journal of Public Health 1998 88 9 1337 1342 (Pubitemid 28402270)
62. Lue L.-F., Brachova L., Civin W. H., Rogers J., Inflammation, Aβ deposition, and neurofibrillary tangle formation as correlates of Alzheimers disease neurodegeneration Journal of Neuropathology and Experimental Neurology 1996 55 10 1083 1088 (Pubitemid 26338020)
63. Itzhaki R. F., Lin W.-R., Shang D., Wilcock G. K., Faragher B., Jamieson G. A., Herpes simplex virus type 1 in brain and risk of Alzheimers disease The Lancet 1997 349 9047 241 244 (Pubitemid 27050990)
64. Itzhaki R. F., Dobson C. B., Lin W.-R., Wozniak M. A., Association of HSV1 and apolipoprotein E- ε4 in Alzheimers disease Journal of NeuroVirology 2001 7 6 570 571
65. Pogo B. G. T., Casals J., Elizan T. S., A study of viral genomes and antigens in brains of patients with Alzheimers disease Brain 1987 110 4 907 915 (Pubitemid 17135218)
66. Friedland R. P., May C., Dahlberg J., The viral hypothesis of Alzheimers disease: absence of antibodies to lentiviruses Archives of Neurology 1990 47 2 177 178 (Pubitemid 20058116)
67. Renvoize E. B., Awad I. O., Hambling M. H., A sero-epidemiological study of conventional infectious agents in Alzheimers disease Age and Ageing 1987 16 5 311 314
68. Miklossy J., Alzheimers diseasea spirochetosis? NeuroReport 1993 4 7 841 848
69. Matthews W. B., Unconventional virus infection and neurological disease Neuropathology and Applied Neurobiology 1986 12 2 111 116
70. Robinson S. R., Dobson C., Lyons J., Challenges and directions for the pathogen hypothesis of Alzheimers disease Neurobiology of Aging 2004 25 5 629 637 (Pubitemid 38686485)
71. Dreses-Werringloer U., Bhuiyan M., Zhao Y., Gérard H. C., Whittum-Hudson J. A., Hudson A. P., Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain International Journal of Medical Microbiology 2009 299 3 187 201
72. Gérard H. C., Wang G. F., Balin B. J., Schumacher H. R., Hudson A. P., Frequency of apolipoprotein E (APOE) allele types in patients with Chlamydia -associated arthritis and other arthritides Microbial Pathogenesis 1999 26 1 35 43
73. Grard H. C., Wildt K. L., Whittum-Hudson J. A., Lai Z., Ager J., Hudson A. P., The load of Chlamydia pneumoniae in the Alzheimers brain varies with APOE genotype Microbial Pathogenesis 2005 39 1-2 19 26 (Pubitemid 41021657)
74. MacIntyre A., Hammond C. J., Little C. S., Appelt D. M., Balin B. J., Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells FEMS Microbiology Letters 2002 217 2 167 172 (Pubitemid 35441301)
75. Little C. S., Hammond C. J., MacIntyre A., Balin B. J., Appelt D. M., Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice Neurobiology of Aging 2004 25 4 419 429 (Pubitemid 38317339)
76. Loeb M. B., Molloy D. W., Smieja M. et al., A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimers disease Journal of the American Geriatrics Society 2004 52 3 381 387 (Pubitemid 38339518)
77. Finefrock A. E., Bush A. I., Doraiswamy P. M., Current status of metals as therapeutic targets in Alzheimers disease Journal of the American Geriatrics Society 2003 51 8 1143 1148
78. Cahoon L., The curious case of clioquinol Nature Medicine 2009 15 4 356 359
79. Contini C., Fainardi E., Seraceni S., Granieri E., Castellazzi M., Cultrera R., Molecular identification and antibody testing of Chlamydophila pneumoniae in a subgroup of patients with HIV-associated dementia complex. Preliminary results Journal of Neuroimmunology 2003 136 1-2 172 177
80. Gartner S., HIV infection and dementia Science 2000 287 5453 602 604
81. Layh-Schmitt G., Bendl C., Hildt U. et al., Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis Annals of Neurology 2000 47 5 652 655
82. Li W. P., Ming X., Cook S., Blumberg B., Dowling P., Chlamydia pneumoniae sequence frequently present in both MS and control spinal fluid Neurology 2000 54 supplement 3 A165
83. Treib J., Haa A., Stille W. et al., Multiple sclerosis and Chlamydia pneumoniae Annals of Neurology 2000 47 3 408
84. Gieffers J., Pohl D., Treib J. et al., Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis Annals of Neurology 2001 49 5 585 589
85. Sotgiu S., Piana A., Pugliatti M. et al., Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls Multiple Sclerosis 2001 7 6 371 374
86. Ikejima H., Haranaga S., Takemura H. et al., PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluids Clinical and Diagnostic Laboratory Immunology 2001 8 3 499 502
87. Hao Q., Miyashita N., Matsui M., Wang H.-Y., Matsushima T., Saida T., Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis Multiple Sclerosis 2002 8 5 436 440
88. Chatzipanagiotou S., Tsakanikas C., Anagnostouli M., Rentzos M., Ioannidis A., Nicolaou C., Detection of Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis by combination of cell culture and PCR. No evidence for possible association Molecular Diagnosis 2003 7 1 41 43
89. Grimaldi L. M. E., Pincherle A. et al., Martinelli-Boneschi F., An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients Multiple Sclerosis 2003 9 5 467 471
90. Rostasy K., Reiber H., Pohl D. et al., Chlamydia pneumoniae in children with MS: frequency and quantity of intrathecal antibodies Neurology 2003 61 1 125 128
91. Dong-Si T., Weber J., Liu Y. B. et al., Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis Journal of Neurology 2004 251 5 542 547 (Pubitemid 38680296)
92. Contini C., Cultrera R., Seraceni S., Castellazzi M., Granieri E., Fainardi E., Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis Multiple Sclerosis 2004 10 4 360 369 (Pubitemid 39117330)
93. Sriram S., Ljunggren-Rose A., Yao S.-Y., Whetsell W. O. Jr., Detection of chlamydial bodies and antigens in the central nervous system of patients with multiple sclerosis Journal of Infectious Diseases 2005 192 7 1219 1228 (Pubitemid 41368422)
94. Sessa R., Schiavoni G., Borriello G. et al., Real time PCR for detection of Chlamydophila pneumoniae in peripheral blood mononuclear cells of patients with multiple sclerosis Journal of Neurology 2007 254 9 1293 1295 (Pubitemid 350112350)
95. Contini C., Seraceni S., Castellazzi M., Granieri E., Fainardi E., Chlamydophila pneumoniae DNA and mRNA transcript levels in peripheral blood mononuclear cells and cerebrospinal fluid of patients with multiple sclerosis Neuroscience Research 2008 62 1 58 61
96. Tang Y.-W., Sriram S., Li H. et al., Qualitative and quantitative detection of Chlamydophila pneumoniae DNA in cerebrospinal fluid from multiple sclerosis patients and controls PLoS ONE 2009 4 4, article e5200
97. Anderson D. W., Ellenberg J. H., Leventhal C. M., Reingold S. C., Rodriguez M., Silberberg D. H., Revised estimate of the prevalence of multiple sclerosis in the United States Annals of Neurology 1992 31 3 333 336
98. Barnett M. H., Sutton I., The pathology of multiple sclerosis: a paradigm shift Current Opinion in Neurology 2006 19 3 242 247 (Pubitemid 43804677)
99. Princeas J. W., Kwon E. E., Cho E.-S., Sharer L. R., Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques Annals of the New York Academy of Sciences 1984 436 11 32
100. Bsibsi M., Ravid R., Gveric D., van Noort J. M., Broad expression of Toll-like receptors in the human central nervous system Journal of Neuropathology and Experimental Neurology 2002 61 11 1013 1021 (Pubitemid 35278723)
101. Joyee A. G., Yang X., Role of toll-like receptors in immune responses to chlamydial infections Current Pharmaceutical Design 2008 14 6 593 600 (Pubitemid 351516882)
102. Seraceni S., Badia L., Grilli A., Fainardi E., Contini C., Role of toll like receptors in patients with multiple sclerosis and Chlamydophila pneumoniae infection Proceedings of the European Congress of Clinical Microbiology and Infectious Diseases May 2009 Helsinki, Finland. abstract no. R2174
103. Gilden D. H., Infectious causes of multiple sclerosis Lancet Neurology 2005 4 3 195 202 (Pubitemid 40269150)
104. Steiner I., Nisipianu P., Wirguin I., Infection and the etiology and pathogenesis of multiple sclerosis Current Neurology and Neuroscience Reports 2001 1 3 271 276
105. Gilden D. H., Chlamydia: a role for multiple sclerosis or more confusion Annals of Neurology 1999 46 1 4 5 (Pubitemid 29314376)
106. Sriram S., Mitchell W., Stratton C., Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS Neurology 1998 50 2 571 572 (Pubitemid 28119826)
107. Sriram S., Stratton C. W., Yao S.-Y. et al., Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis Annals of Neurology 1999 46 1 6 14 (Pubitemid 29314377)
108. Stratton C. W., Wheldon D. B., Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae Trends in Microbiology 2006 14 11 474 479
109. Fainardi E., Castellazzi M., Seraceni S., Granieri E., Contini C., Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis Current Neurovascular Research 2008 5 1 60 70 (Pubitemid 351302656)
110. Munger K. L., Peeling R. W., Hernn M. A., Infection with Chlamydia pneumoniae and risk of multiple sclerosis Epidemiology 2003 14 2 141 147 (Pubitemid 40417099)
111. Munger K. L., DeLorenze G. N., Levin L. I., A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts Neurology 2004 62 10 1799 1803 (Pubitemid 38661738)
112. Buljevac D., Verkooyen R. P., Jacobs B. C., Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients Annals of Neurology 2003 54 6 828 831 (Pubitemid 37498967)
113. Hammerschlag M. R., Ke Z., Lu F., Roblin P., Boman J., Kalman B., Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis? Journal of Clinical Microbiology 2000 38 11 4274 4276 (Pubitemid 32233246)
114. Boman J., Roblin P. M., Sundström P., Sandström M., Hammerschlag M. R., Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS Neurology 2000 54 1 265 (Pubitemid 30038781)
115. Poland S. D., Rice G. P. A., Chlamydia pneumoniae and multiple sclerosis Neurology 2000 54 supplement 3 A165
116. Furrows S. J., Hartley J. C., Bell J., Chlamydophila pneumoniae infection of the central nervous system in patients with multiple sclerosis Journal of Neurology, Neurosurgery and Psychiatry 2004 75 1 152 154 (Pubitemid 38091289)
117. Cirino F., Webley W. C., West C., Croteau N. L., Andrezejewski C. Jr., Stuart E. S., Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques BMC Infectious Diseases 2006 6, article 23
118. Yamamoto Y., PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids Clinical and Diagnostic Laboratory Immunology 2002 9 3 508 514
119. Mahony J. B., Chong S., Coombes B. K., Smieja M., Petrich A., Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells Journal of Clinical Microbiology 2000 38 7 2622 2627
120. Kaufman M., Gaydos C. A., Sriram S., Boman J., Tondella M. L., Norton H. J., Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results Multiple Sclerosis 2002 8 4 289 294
121. Sriram S., Yao S.-Y., Stratton C., Comparative study of the presence of Chlamydia pneumoniae in cerebrospinal fluid of patients with clinically definite and monosymptomatic multiple sclerosis Clinical and Diagnostic Laboratory Immunology 2002 9 6 1332 1337
122. Saiz A., Marcos M. A., Graus F., Vidal J., Jimenez de Anta M. T., No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis Journal of Neurology 2001 248 7 617 618
123. Derfuss T., Grkov R., Bergh F. T. et al., Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response Brain 2001 124 7 1325 1335 (Pubitemid 32606094)
124. Budak F., Keeli S., Efendi H., Budak F., Vahabolu H., The investigation of Chlamydophila pneumoniae in patients with multiple sclerosis International Journal of Neuroscience 2007 117 3 409 415 (Pubitemid 46256490)
125. Morré S. A., de Groot C. J. A., Killestein J. et al., Is Chlamydia pneumoniae present in the central nervous system of multiple sclerosis patients? Annals of Neurology 2000 48 3 399
126. Pucci E., Taus C., Cartechini E.et al., Lack of Chlamydia infection of the central nervous system in multiple sclerosis Annals of Neurology 2000 48 3 399 400
127. Thompson E. J., Freedman M. S., Cerebrospinal fluid analysis in the diagnosis of multiple sclerosis Advances in Neurology 2006 98 147 160
128. Smith-Jensen T., Burgoon M. P., Anthony J., Kraus H., Gilden D. H., Owens G. P., Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response Neurology 2000 54 6 1227 1232 (Pubitemid 30174038)
129. Krametter D., Niederwieser G., Berghold A. et al., Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker Multiple Sclerosis 2001 7 1 13 18 (Pubitemid 32396573)
130. Franciotta D., Zardini E., Bergamaschi R., Grimaldi L. M., Andreoni L., Cosi V., Analysis of Chlamydia pneumoniae -specific oligoclonal bands in multiple sclerosis and other neurologic diseases Acta Neurologica Scandinavica 2005 112 4 238 241 (Pubitemid 41337071)
131. Fainardi E., Castellazzi M., Casetta I. et al., Intrathecal production of Chlamydia pneumoniae -specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms Journal of the Neurological Sciences 2004 217 2 181 188 (Pubitemid 38056553)
132. Bagos P. G., Nikolopoulos G., Ioannidis A., Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis Multiple Sclerosis 2006 12 4 397 411 (Pubitemid 44132580)
133. Metz L. M., Zhang Y., Yeung M. et al., Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis Annals of Neurology 2004 55 5 756 (Pubitemid 38544341)
134. Sriram S., Yao S. Y., Stratton C., Moses H., Narayana P. A., Wolinsky J. S., Pilot study to examine the effect of antibiotic therapy on MRI outcomes in RRMS Journal of the Neurological Sciences 2005 234 1-2 87 91 (Pubitemid 40910348)
135. Stratton C. W., Wheldon D. B., Antimicrobial treatment of multiple sclerosis Infection 2007 35 5 383 385
136. Contini C., International conference on chlamydial and Mycoplasma human infections Future Microbiology 2007 2 4 373 376 (Pubitemid 47365022)
137. Contini C., Seraceni S., Cultrera R., Castellazzi M., Granieri E., Fainardi E., Molecular detection of Parachlamydia -like organisms in cerebrospinal fluid of patients with multiple sclerosis Multiple Sclerosis 2008 14 4 564 566 (Pubitemid 351943874)
138. Gilden D. H., Devlin M. E., Burgoon M. P., Owens G. P., The search for virus in multiple sclerosis brain Multiple Sclerosis 1996 2 4 179 183
139. Álvarez-Lafuente R., De las Heras V., Bartolomé M., Picazo J. J., Arroyo R., Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection Archives of Neurology 2004 61 10 1523 1527 (Pubitemid 39350262)
140. Moore F. G. A., Wolfson C., Human herpes virus 6 and multiple sclerosis Acta Neurologica Scandinavica 2002 106 2 63 83 (Pubitemid 34831922)
141. Christensen T., The role of EBV in MS pathogenesis International MS Journal 2006 13 2 52 57 (Pubitemid 43764528)
142. Clark D., Human herpesvirus type 6 and multiple sclerosis Herpes 2004 11 supplement 2 112A 119A
143. DeLorenze G. N., Munger K. L., Lennette E. T., Orentreich N., Vogelman J. H., Ascherio A., Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up Archives of Neurology 2006 63 6 839 844 (Pubitemid 43882291)
144. Hllsberg P., Kusk M., Bech E., Hansen H. J., Jakobsen J., Haahr S., Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity Acta Neurologica Scandinavica 2005 112 6 395 402 (Pubitemid 41695720)
145. van Noort J. M., Bajramovic J. J., Plomp A. C., van Stipdonk M. J. B., Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis Journal of Neuroimmunology 2000 105 1 46 57
146. Cepok S., Zhou D., Srivastava R. et al., Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis Journal of Clinical Investigation 2005 115 5 1352 1360 (Pubitemid 40629055)
147. Dolei A., MSRV/HERV-W/syncytin and its linkage to multiple sclerosis: the usability and the hazard of a human endogenous retrovirus Journal of NeuroVirology 2005 11 2 232 235 (Pubitemid 40852431)
148. Fryden A., Kihlstrom E., Maller R., Persson K., Romanus V., Ansehn S., A clinical and epidemiological study of ornithosis caused by Chlamydia psittaci and Chlamydia pneumoniae (strain TWAR) Scandinavian Journal of Infectious Diseases 1989 21 6 681 691 (Pubitemid 20013711)
149. Haidl S., Ivarsson S., Bjerre I., Persson K., Guillain-Barré syndrome after Chlamydia pneumoniae infection The New England Journal of Medicine 1992 326 8 576 577
150. Michel D., Antoine J. C., Pozzetto B., Gaudin O. G., Lucht F., Lumbosacral meningoradiculitis associated with Chlamydia pneumoniae infection Journal of Neurology Neurosurgery and Psychiatry 1992 55 6 511
151. Sundelöf B., Gnarpe H., Gnarpe J., An unusual manifestation of Chlamydia pneumoniae infection: meningitis, hepatitis, iritis and atypical erythema nodosum Scandinavian Journal of Infectious Diseases 1993 25 2 259 261 (Pubitemid 23149017)
152. Socan M., Beovic B., Kese D., Chlamydia pneumonia and meningoencephalitis The New England Journal of Medicine 1994 331 6 406
153. Koskiniemi M., Korppi M., Mustonen K., Epidemiology of encephalitis in children. A prospective multicentre study European Journal of Pediatrics 1997 156 7 541 545 (Pubitemid 27289853)
154. Korman T. M., Turnidge J. D., Grayson M. L., Neurological complications of chlamydial infections: case report and review Clinical Infectious Diseases 1997 25 4 847 851 (Pubitemid 27443854)
155. Heick A., Skriver E., Chlamydia pneumoniae -associated ADEM European Journal of Neurology 2000 7 4 435 438
156. Guglielminotti J., Lellouche N., Maury E., Alzieu M., Guidet B., Offenstadt G., Severe meningoencephalitis: an unusual manifestation of Chlamydia pneumoniae infection Clinical Infectious Diseases 2000 30 1 209 210 (Pubitemid 30067087)
157. Anton E., Otegui A., Alonso A., Meningoencephalitis and Chlamydia pneumoniae infection European Journal of Neurology 2000 7 5 586
158. Airas L., Kotilainen P., Vainionpää R., Marttila R. J., Encephalitis associated with Chlamydia pneumoniae Neurology 2001 56 12 1778 1779 (Pubitemid 32574590)
159. Boschin-Crinquette C., Kreisler A., Legout L., Charpentier P., Deste A., Defebvre L., Can meningoencephalitis be caused by Chlamydiae pneumoniae ? Revue Neurologique 2005 161 10 979 983 (Pubitemid 41499776)
160. Wing L., Leekam S. R., Libby S. J., Gould J., Larcombe M., The diagnostic interview for social and communication disorders: background, inter-rater reliability and clinical use Journal of Child Psychology and Psychiatry and Allied Disciplines 2002 43 3 307 325 (Pubitemid 36939220)
161. Folstein S. E., Rosen-Sheidley B., Genetics of autism: complex aetiology for a heterogeneous disorder Nature Reviews Genetics 2001 2 12 943 955 (Pubitemid 33691091)
162. Veenstra-vanderweele J., Cook E. H. Jr., Lombroso P. J., Genetics of childhood disorders: XLVI. Autism, part 5: genetics of autism Journal of the American Academy of Child and Adolescent Psychiatry 2003 42 1 116 118 (Pubitemid 39610621)
163. Takahashi H., Arai S., Tanaka-Taya K., Okabe N., Autism and infection/immunization episodes in Japan Japanese Journal of Infectious Diseases 2001 54 2 78 79 (Pubitemid 32685455)
164. Yamashita Y., Fujimoto C., Nakajima E., Isagai T., Matsuishi T., Possible association between congenital cytomegalovirus infection and autistic disorder Journal of Autism and Developmental Disorders 2003 33 4 455 459 (Pubitemid 37127942)
165. Libbey J. E., Sweeten T. L., McMahon W. M., Fujinami R. S., Autistic disorder and viral infections Journal of NeuroVirology 2005 11 1 1 10
166. Thornton D. H., A survey of mycoplasma detection in veterinary vaccines Vaccine 1986 4 4 237 240
167. Chia J. K. S., Chia L. Y., Chronic Chlamydia pneumoniae infection: a treatable cause of chronic fatigue syndrome Clinical Infectious Diseases 1999 29 2 452 453 (Pubitemid 29380223)
168. Nicolson R., Szatmari P., Genetic and neurodevelopmental influences in autistic disorder Canadian Journal of Psychiatry 2003 48 8 526 537 (Pubitemid 37280042)
169. Huang W., See D., Tiles J., The prevalence of Mycoplasma incognitus in the peripheral blood mononuclear cells of normal controls or patients with AIDS or chronic fatigue syndrome Journal of Clinical Microbiology 1998 231 457 467 (Pubitemid 128533430)
170. Nijs J., Nicolson G. L., De Becker P., Coomans D., De Meirleir K., High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients FEMS Immunology and Medical Microbiology 2002 34 3 209 214 (Pubitemid 35335521)
171. Nicolson G. L., Gan R., Haier J., Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms APMIS: Acta Pathologica, Microbiologica et Immunologica Scandinavica 2003 111 5 557 566 (Pubitemid 36963175)
172. Nicolson G. L., Chronic bacterial and viral infections in neurodegenerative and neurobehavioral diseases Laboratory Medicine 2008 39 5 291 299
173. Campadelli-Fiume G., Mirandola P., Menotti L., Human herpesvirus 6: an emerging pathogen Emerging Infectious Diseases 1999 5 3 353 366 (Pubitemid 29289449)
174. Keen D., Ward S., Austistic spectrum disorder: a child population profile Autism 2004 8 1 39 48 (Pubitemid 38239621)
175. Fellerhoff B., Laumbacher B., Wank R., High risk of schizophrenia and other mental disorders associated with chlamydial infections: hypothesis to combine drug treatment and adoptive immunotherapy Medical Hypotheses 2005 65 2 243 252 (Pubitemid 40744749)